NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









Elevage Medical Technologies

Elevage Medical Technologies

Private
Austin, TexasFinTechhttps://www.elevagemed.com/

Last Round

Corporate Funding

May 1, 2023

Total Funding Raised

$300M

Momentum Score

50 /100

Company Overview

Elevage Medical Technologies is a portfolio company of Patient Square Capital, formed in 2023 with a $300 million capital commitment. The company's mission is to acquire, invest in, and accelerate the development of growth-stage medical device companies. It provides both capital and strategic operational support to advance the approval and commercialization of innovative medical technologies that can improve patient health outcomes and quality of life. The company is led by CEO Evan Melrose, M.D., a veteran of healthcare investment.

Sector

FinTech

Verticals

Investment Platforms, Medical Devices, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

investment platformmedtech investormedical device fundinggrowth equityhealthcare venture capitalmedtech commercializationlife sciences investmentstrategic operational supportclinical development supportregulatory expertiseminimally invasive surgeryregenerative medicinebioelectronic medicineremote patient monitoring

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Elevage Medical Technologies Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Elevage Medical Technologies Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingMay 1, 2023

Elevage Medical Technologies Investors

Notable investors and investment history

InvestorRounds
Patient Square CapitalCorporate Funding

Elevage Medical Technologies Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Elevage Medical Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Elevage Medical Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersAustin, Texas
Employee Range17
Year Founded2023
Last FundingMay 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.